Exploiting the opposing actions of complement receptors C3aR and C5aR1 in the treatment of MND (2016–2017)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc